Highlights Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:10:00 18/06/2025 BST			5-day change	1st Jan Change
101.37 ^USD	-0.35%		+1.98%	+13.49%

06-16	Leerink Partners Initiates Boston Scientific at Outperform With $118 Price Target	MT
06-05	Bittium Enters ECG Monitoring Device Deal with Boston Scientific	MT

Highlights

Worldwide Healthcare Trust trails benchmark in "challenging" year	06-11	AN
Bittium Enters ECG Monitoring Device Deal with Boston Scientific	06-05	MT
Bittium Biosignals Ltd. and Boston Scientific Have Signed an Agreement for the Supply of Electrocardiogram Monitoring Devices	06-04	CI
Bittium's Unit Extends Deal With Boston Scientific	06-04	RE
Boston Scientific to stop heart device sales amid regulatory challenges	05-28	RE
Boston Scientific Ends Global Sales of Acurate Valve Systems; Reaffirms Q2, 2025 Sales, Adjusted EPS Guidance	05-28	MT
Boston Scientific Ending Acurate Sales, Approval Efforts	05-28	DJ
Boston Scientific to not seek US approval for heart device amid regulatory challenges	05-28	RE
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit	05-01	RE
Tranche Update on Boston Scientific Corporation's Equity Buyback Plan announced on December 14, 2020.	05-01	CI
Boston Scientific Corporation Announces Positive 12-Month Primary Endpoint Results from the Second Phase of the Advanceage Af Clinical Trial Evaluating the Use of the Farapulse Pulsed Field Ablation System	04-24	CI
Edwards Lifesciences raises 2025 sales forecast after robust quarter	04-23	RE
Sector Update: Health Care Stocks Higher in Afternoon Trading	04-23	MT
Boston Scientific Raises Full-Year Outlook Following First-Quarter Beat, Names New CFO	04-23	MT
Boston Scientific lifts profit view as robust demand expected to shield tariff impact	04-23	RE
Sector Update: Health Care Stocks Flat to Higher Premarket Wednesday	04-23	MT
Wall St set to jump as Trump says he has no plans to fire Powell; Tesla leaps	04-23	RE
Sector Update: Health Care	04-23	MT
Boston Scientific Shares Higher on Rosy Outlook, 1Q Beats	04-23	DJ
Boston Scientific raises 2025 profit forecast on strong heart device sales	04-23	RE
Boston Scientific's Q1 Adjusted Earnings, Sales Increase	04-23	MT
(BSX) Boston Scientific Expects Full Year 2025 Adjusted EPS Range $2.87 - $2.94, vs. FactSet Est of $2.79	04-23	MT
(BSX) Boston Scientific Expects Q2 Adjusted EPS Range $0.71 - $0.73, vs. FactSet Est of $0.68	04-23	MT
Boston Scientific Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	04-23	CI
Earnings Flash (BSX) Boston Scientific Posts Q1 Adjusted EPS $0.75, vs. FactSet Est of $0.63	04-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Boston Scientific: Is the price justified?

January 31, 2025 at 08:26 am